Hyderabad: Aurobindo Pharma Ltd has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Tamsulosin Hydrochloride Capsules and Clindamycin Palmitate Hydrochloride for Oral Solution.
Tamsulosin Hydrochloride Capsule is the generic equivalent of Boehringer Ingelheim Pharmaceuticals’ Flomax Capsules and is indicated for the treatment of symptoms of an enlarged prostate (Benign Prostatic Hyperplasia - BPH) in men.
Clindamycin Palmitate Hydrochloride for Oral Solution is the generic equivalent of Pharmacia & Upjohn’s Cleocin Pediatric. It is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria in infants.
The products would be launched soon, the Hyderabad-based company said in a release on Saturday.
No comments:
Post a Comment